ACTELION LTD | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (34)

View All

Latest Posts

About This Stock More About This Stock
Sarepta Seen As 'Bargain' For Potential Big Pharma Buyer
Article By: The Fly
Thursday, June 8, 2017 3:48 PM EDT
While approval for Sarepta Therapeutic's Exondys 51 in the U.S. was controversial, Oppenheimer analyst Hartaj Singh said it has resulted in a "high level" of short interest and the company would be a "bargain" if it is acquired.
In this article: SRPT Also: ALIOF, PFE, JNJ, TKPYY
Read
Global Stock Index On Verge Of All-Time High Propelled By "Dow 20,000" Euphoria
Article By: Tyler Durden
Thursday, January 26, 2017 7:15 AM EDT
The next big milestone on deck is the S&P 2,300 - also the year end target for roughly half of Wall Street strategists- which should be taken out shortly after the open.
In this article: DIA Also: ALIOF, SPY, JNJ, EBAY, VZ, UUP, COP, UL
Read
Biotech Stock Roundup: Synergy Drug Gets FDA Nod, AbbVie, GILD HCV Drugs Under EU Review
Article By: Arpita Dutt
Wednesday, January 25, 2017 2:07 PM EDT
There were quite a few updates on the regulatory front this week with Synergy gaining FDA approval for its constipation drug, while both Gilead and AbbVie got accelerated assessment for their HCV drugs in the EU.
In this article: SGYP, GILD, ABBV, ALIOF, JNJ, VRTX, REGN, CELG
Read
Pfizer-Medivation Close To Signing $14B Acquisition Deal?
Article By: Arpita Dutt
Monday, August 22, 2016 5:24 AM EDT
Pfizer Inc. and Medivation, Inc. are close to signing a deal under which Pfizer will acquire Medivation for more than $80 per share (approximately $14 billion).
In this article: PFE, MDVN Also: SNY, ALIOF
Read
J&J's Depression Treatment Esketamine Gets BTD
Article By: Arpita Dutt
Wednesday, August 17, 2016 10:33 AM EDT
Johnson & Johnson's Janssen Research & Development, LLC announced that the FDA has granted Breakthrough Therapy Designation to esketamine, an experimental antidepressant treatment.
In this article: JNJ Also: ALIOF, GERN, ABBV
Read
All Posts

Latest Tweets for $ALIOF

No tweets yet!

PARTNER HEADLINES